Hey GAC. That is a very prudent positioning. At this stage I am very concerned about communication of trial results (whenever they occur) because communications is one of the very big Achillies Heels at RVX. ASSURE and June of 2013 is burned in my brain.

In terms of trial length I'm not at all surprised at the current situation based on my very simple calculations from Sept 12 th 2018. My approach is very simple so I didn't post given all of the incredible analysis other posters were providing. I still haven't caught up on reading posts on Agora.

My current thinking is that RVX should not announce anything until the full analysis is done probably some time in 2020 if RVX in fact can control the agenda. Just my opinion based on if the results are not outstanding but the secondary analysis is remarkable at least it may not be as bad as June 2013.

Just a thought.

Toinv